RecruitingPhase 4NCT05557279

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks - a Single-center Study

Sponsor

Loyola University

Enrollment

40 participants

Start Date

Jan 1, 2023

Study Type

INTERVENTIONAL

Conditions

Overactive Bladder

Summary

The purpose of this study is to learn about how the use of 500 mg of dried cranberry powder extract (NDS-446) changes the bacteria that normal reside in the bladder of women who don't have urinary leakage problems but do have problems with urinary urgency and frequency.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 500 mg NDS-446 for people with overactive bladder. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG500 mg NDS-446

All participants will receive 500 mg NDS-446 daily for 12 weeks following a baseline assessment

Locations(1)

Loyola Medical Center

Maywood, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05557279

Related Trials

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT0651114120 locations

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

NCT058789511 location